Workshop Date and Time
Friday, November 8, 2019, 1:30 – 2:30 pm, Eastern Time Register Now
Registrants can listen in live over the phone or online as a webcast.
- Overview of Acute Myelogenous Leukemia (AML)
- Current Treatment Options
- Transplantation as a Treatment Option for AML
- New Therapies
- The Role of Clinical Trials
- Clinical Trial Updates
- Symptom, Side Effect & Pain Management Tips
- Key Questions to Ask Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts
Farhad Ravandi-Kashani, MD
Janiece and Stephen A. Lasher Professor of Medicine, Chief, Section of Departmental Therapeutics, Department of Leukemia, The University of Texas MD Anderson Cancer Center
Mary-Elizabeth Percival, MD, MS
Assistant Professor, Division of Hematology, University of Washington School of Medicine, Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Attending Physician, Seattle Cancer Care Alliance
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).
To request continuing education paperwork, please email your name, profession, and address to email@example.com after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.
You can download the brochure for this workshop(80.8 KB)